Current Pharmaceutical Design

Meet Our Editorial Board Member:
pp. 3273-3273(1)
Author: V. Kabanov, Alexander

Editorial (Thematic Issue: Off-label Treatments for Mental Health: Inappropriate or Unavoidable? A Special Issue to Help Get Through the Maze)
pp. 3274-3275(2)
Authors: Rolland, Benjamin; Amad, Ali

Sense and Sensibility When Prescribing ‘Off-Label’ to Psychiatric Patients
pp. 3276-3279(4)
Authors: S. Baldwin, David; Tiwari, Nupur; Gordon, Robert

Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends
pp. 3280-3297(18)
Authors: Carton, Louise; Cottencin, Olivier; Lapeyre-Mestre, Maryse; A. Geoffroy, Pierre; Favre, Jonathan; Simon, Nicolas; Bordet, Regis; Rolland, Benjamin

Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety
pp. 3298-3305(8)
Authors: Laprevote, Vincent; Schwan, Raymund; Schwitzer, Thomas; Rolland, Benjamin; Thome, Johannes

Off-Label Use of Medications for Treatment of Benzodiazepine Use Disorder
pp. 3306-3310(5)
Authors: Sabioni, Pamela; Bertram, Jonathan; Le Foll, Bernard

Borderline Personality Disorder and Oxytocin: Review of Clinical Trials and Future Directions
pp. 3311-3316(6)
Authors: Amad, Ali; Thomas, Pierre; Mercedes Perez-Rodriguez, M.

Emerging Drugs and Indications for Cardio-Metabolic Disorders in People with Severe Mental Illness
pp. 3317-3324(8)
Authors: Kouidrat, Youssef; Amad, Ali; De Hert, Marc

Novel Indications for Benzodiazepine Antagonist Flumazenil in GABA Mediated Pathological Conditions of the Central Nervous System
pp. 3325-3342(18)
Authors: Hulse, Gary; Kelty, Erin; Hood, Sean; Norman, Amanda; Rita Basso, Maria; Stuart Reece, Albert

Off-Label Trazodone Prescription: Evidence, Benefits and Risks
pp. 3343-3351(9)
Authors: Bossini, Letizia; Coluccia, Anna; Casolaro, Ilaria; Benbow, Jim; Amodeo, Giovanni; De Giorgi, Riccardo; Fagiolini, Andrea

Melatonin and Melatonin Agonists as Adjunctive Treatments in Bipolar Disorders
pp. 3352-3358(7)
Authors: Alexis Geoffroy, Pierre; Etain, Bruno; Micoulaud Franchi, Jean-Arthur; Bellivier, Frank; Ritter, Philipp

Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders
pp. 3359-3366(8)
Authors: Simon, Nicolas; Rolland, Benjamin; Karila, Laurent

GABAB Agonists for the Treatment of Alcohol Use Disorder
pp. 3367-3372(6)
Authors: Mirijello, Antonio; Caputo, Fabio; Vassallo, Gabriele; Rolland, Benjamin; Tarli, Claudia; Gasbarrini, Antonio; Addolorato, Giovanni

Transcranial Direct Current Stimulation for the Treatment of Refractory Symptoms of Schizophrenia. Current Evidence and Future Directions
pp. 3373-3383(11)
Authors: Mondino, Marine; Brunelin, Jerome; Palm, Ulrich; R. Brunoni, Andre; Poulet, Emmanuel; Fecteau, Shirley

Current Issues in the Use of fMRI-Based Neurofeedback to Relieve Psychiatric Symptoms
pp. 3384-3394(11)
Authors: Fovet, Thomas; Jardri, Renaud; Linden, David

Gender Based Differences in Stress-induced Gastric Ulcer Formation and its Regulation by Nitric Oxide (NO): An Experimental Study
pp. 3395-3401(7)
Authors: Gulati, Kavita; Chakraborti, Ayanabha; Ray, Arunabha

MicroRNAs in Esophageal Adenocarcinoma: Functional Significance and Potential for the Development of New Molecular Disease Markers
pp. 3402-3416(15)
Authors: V. Bobryshev, Yuri; N. Orekhov, Alexander; A. Chistiakov, Dmitry

Synthesis of Apoptotic New Quinazolinone-Based Compound and Identification of its Underlying Mitochondrial Signalling Pathway in Breast Cancer Cells
pp. 3417-3426(10)
Authors: Zahedifard, Maryam; Lafta Faraj, Fadhil; Paydar, Mohammadjavad; Yeng Looi, Chung; Hasandarvish, Pouya; Hajrezaie, Maryam; Kamalidehghan, Behnam; Abdul Majid, Nazia; A.M. Khalifa, Shaden; Mohd Ali, Hapipah; Ameen Abdulla, Mahmood; R. El-Seedi, Hesham